{"id":"W4283798749","doi":"10.1136/ard-2022-222608","title":"Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":false,"ca_institutions":"Arthritis Society; University of Toronto; University Health Network","funders":"AbbVie","keywords":"Medicine; Ankylosing spondylitis; Placebo; Clinical endpoint; Internal medicine; Adverse effect; BASDAI; Tolerability; Spondylitis; Randomized controlled trial; Arthritis; Psoriatic arthritis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002573757,0.002557284,0.005965685,0.0005487491,0.0008046807,0.001842135,0.001266788,0.003712101,0.007494404],"category_scores_gemma":[0.002517901,0.001062349,0.003278154,0.0005709883,0.002237717,0.001932406,0.0005271992,0.004773424,0.00146404],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009665659,"about_ca_system_score_gemma":0.001192345,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009922151,"about_ca_topic_score_gemma":0.00173543,"domain_scores_codex":[0.9990202,0.000463229,0.00006147556,0.0001833413,0.00007855402,0.0001930932],"domain_scores_gemma":[0.9986107,0.0004702087,0.0002817499,0.0001203702,0.0001082472,0.0004086955],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9898615,0.002079789,0.0001874055,0.0005653299,0.0007201865,0.00002802487,0.00003198596,0.000134589,0.001020418,0.00005387195,0.0004163261,0.004900552],"study_design_scores_gemma":[0.9779487,0.02046043,0.0006036555,0.00002560549,0.0003717935,0.0000225819,0.00001152935,0.0001460885,0.0001358028,0.00006771318,0.0001941206,0.00001206549],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9776033,0.0114521,0.0009029189,0.0008637242,0.001016371,0.00418428,0.001428877,0.0001857549,0.002362553],"genre_scores_gemma":[0.9856668,0.003868808,0.00104052,0.001283569,0.000598632,0.003768088,0.001271531,0.00003873164,0.002463308],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007494404,"threshold_uncertainty_score":0.0250712,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1075971404778814,"score_gpt":0.3830250904359073,"score_spread":0.2754279499580259,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}